Cite
Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: rapid response to imatinib mesylate (STI571)
MLA
Shigeyoshi Hibi, et al. “Chronic Myeloid Leukemia in a Patient with Chronic Idiopathic Thrombocytopenic Purpura: Rapid Response to Imatinib Mesylate (STI571).” Medical and Pediatric Oncology, vol. 41, no. 2, June 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a4ffe22c12fcbe45cae7003019ae4dd6&authtype=sso&custid=ns315887.
APA
Shigeyoshi Hibi, Kikuko Kuriyama, Gen Kano, Shinsaku Imashuku, Shinjiro Todo, & Akira Morimoto. (2003). Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: rapid response to imatinib mesylate (STI571). Medical and Pediatric Oncology, 41(2).
Chicago
Shigeyoshi Hibi, Kikuko Kuriyama, Gen Kano, Shinsaku Imashuku, Shinjiro Todo, and Akira Morimoto. 2003. “Chronic Myeloid Leukemia in a Patient with Chronic Idiopathic Thrombocytopenic Purpura: Rapid Response to Imatinib Mesylate (STI571).” Medical and Pediatric Oncology 41 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a4ffe22c12fcbe45cae7003019ae4dd6&authtype=sso&custid=ns315887.